To investigate endogenous testosterone density (ETD) predicting disease progression from clinically localized impalpable prostate cancer (PCa) presenting with prostate-specific antigen (PSA) levels elevated up to 10 ng/mL and treated with radical prostatectomy.
Preoperative endogenous testosterone density predicts disease progression from localized impalpable prostate cancer presenting with PSA levels elevated up to 10 ng/mL
Porcaro, Antonio Benito
;Bianchi, Alberto;Mazzucato, Giovanni;Gallina, Sebastian;Serafin, Emanuele;Tafuri, Alessandro;Cerrato, Clara;Panunzio, Andrea;Vidiri, Stefano;D'Aietti, Damiano;Orlando, Rossella;Brusa, Davide;Brunelli, Matteo;Cerruto, Maria Angela;Antonelli, Alessandro
2023-01-01
Abstract
To investigate endogenous testosterone density (ETD) predicting disease progression from clinically localized impalpable prostate cancer (PCa) presenting with prostate-specific antigen (PSA) levels elevated up to 10 ng/mL and treated with radical prostatectomy.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
